8 reports

VERISANTE CORE - GASTROINTESTINAL CANCER VERISANTE CORE - GASTROINTESTINAL CANCER PRODUCT OVERVIEW VERISANTE CORE - GASTROINTESTINAL CANCER - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage of Development Source: Primary / Secondary Resear

  • Skin Cancer
  • Canada
  • United States
  • GlobalData's company
  • Verisante Technology, Inc.

SYSTEMIC TETRACYCLINE MAY CAUSE GASTROINTESTINAL UPSET, NAUSEA, DIARRHEA, AND VAGINAL YEAST INFECTION.

  • Skin Cancer
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Skin Cancer
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • Verisante Technology Inc - Company Statement

One in seven Canadians will develop skin cancer during their lifetime while one in five Americans will and over ##. ## million cases of skin cancer are diagnosed annually in the USA.

  • Skin Cancer
  • United States
  • World
  • Company Financials
  • Verisante Technology, Inc.
  • APR 20, 2016: EXELIXIS ANNOUNCES PRESENTATION ON COBIMETINIB AT 2016 ASCO ANNUAL MEETING

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Colorectal Cancer
  • Skin Cancer
  • Targeted Therapy
  • United States
  • Novartis AG
  • Therapy Area Indication(s)

## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## Japan Source: Glob

  • Cancer
  • Skin Cancer
  • Therapy
  • World
  • Product Initiative
  • APR 20, 2016: EXELIXIS ANNOUNCES PRESENTATION ON COBIMETINIB AT 2016 ASCO ANNUAL MEETING

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Cancer
  • Skin Cancer
  • United States
  • Product Initiative
  • Novartis AG
  • BIOMARKER TEST FOR IMMUNE CHECKPOINT INHIBITOR THERAPY - PRODUCT DESCRIPTION

Its treatment centers include blood Cancer, breast cancer, cancer genetics and prevention, cutaneous (skin) cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, head and neck cancer, and hematology.

  • Biomarker
  • Skin Cancer
  • United States
  • Company
  • GlobalData's company